Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States

Pharmacogenomics, which is defined as the study of changes in the properties of DNA and RNA associated with drug response, enables the prediction of the efficacy and adverse effects of drugs based on patients’ specific genetic mutations. For the safe and effective use of drugs, it is important that...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Mijin, Han, Ji Min, Lee, Jaeyeon, Oh, Ju Young, Kim, Jung Sun, Gwak, Hye Sun, Choi, Kyung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285385/
https://www.ncbi.nlm.nih.gov/pubmed/37361213
http://dx.doi.org/10.3389/fphar.2023.1205624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285385/
https://www.ncbi.nlm.nih.gov/pubmed/37361213
http://dx.doi.org/10.3389/fphar.2023.1205624

Ejemplares similares